NRX Pharmaceuticals, Inc.
NRXP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001719406
No open-market purchases or sales by NRX Pharmaceuticals, Inc. insiders were filed in the last 90 days; 47 institutions reported holding it in 13F filings for Q2 2026, worth $47.6M in total; no superinvestor holds it.
13F holders, Q4 2025
Institutional positions in NRX Pharmaceuticals, Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 28
- +4 vs. Q3 2025
- Shares held
- 5.24M
- +1.28M (+32.3%) vs. Q3 2025
- Total value
- $14.2M
- +$1.13M (+8.6%) vs. Q3 2025
- New holders
- 7
- 7 more added
- Sold out
- 3
- 9 more reduced
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NRXP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 47 | $47.6M |
| Q1 2026 | 33 | $13.2M |
| Q4 2025 | 28 | $14.2M |
| Q3 2025 | 24 | $13.0M |
| Q2 2025 | 25 | $9.76M |
| Q1 2025 | 22 | $4.60M |
| Q4 2024 | 25 | $2.31M |
| Q3 2024 | 18 | $1.21M |
| Q2 2024 | 19 | $1.29M |
| Q1 2024 | 31 | $1.76M |
| Q4 2023 | 30 | $1.84M |
| Q3 2023 | 34 | $964.7K |
| Q2 2023 | 32 | $4.78M |
| Q1 2023 | 30 | $2.07M |
| Q4 2022 | 33 | $3.44M |
| Q3 2022 | 30 | $3.04M |
| Q2 2022 | 37 | $2.18M |
| Q1 2022 | 34 | $25.1M |
| Q4 2021 | 38 | $12.4M |
| Q3 2021 | 23 | $16.2M |
| Q2 2021 | 18 | $18.9M |
| Q1 2021 | 1 | $4.00K |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding NRX Pharmaceuticals, Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Anson Funds Management LP | 3,043,957 | $8.25M | 1.15% | +1,018,853+50.3% | Added |
| Vanguard Group Inc | 729,842 | $1.98M | 0.00% | +194,886+36.4% | Added |
| Commonwealth Equity Services, LLC | 366,631 | $993.6K | 0.00% | +366,631 | New |
| AdvisorShares Investments LLC | 328,004 | $888.9K | 0.15% | −14,132−4.1% | Reduced |
| Geode Capital Management, LLC | 218,866 | $593.2K | 0.00% | +33,004+17.8% | Added |
| Bleakley Financial Group, LLC | 117,204 | $317.6K | 0.01% | +117,204 | New |
| State Street Corp | 86,984 | $235.7K | 0.00% | +10,700+14.0% | Added |
| BlackRock, Inc. | 82,654 | $224.0K | 0.00% | +17,242+26.4% | Added |
| Global Retirement Partners, LLC | 39,300 | $106.5K | 0.00% | +39,300 | New |
| Jane Street Group, LLC | 38,065 | $103.2K | 0.00% | −35,334−48.1% | Reduced |
| One Wealth Management Investment & Advisory Services, LLC | 37,873 | $102.6K | 0.11% | +9,882+35.3% | Added |
| Northern Trust Corp | 28,947 | $78.4K | 0.00% | +346+1.2% | Added |
| Chicago Partners Investment Group LLC | 33,421 | $72.5K | 0.00% | −8,573−20.4% | Reduced |
| Two Sigma Investments, LP | 17,436 | $47.3K | 0.00% | −34,896−66.7% | Reduced |
| Point72 Asset Management, L.P. | 15,979 | $43.3K | 0.00% | +15,979 | New |
| Sjbenen Advisory, LLC | 15,000 | $40.6K | 0.04% | +15,000 | New |
| Ethos Financial Group, LLC | 11,900 | $32.2K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 10,029 | $27.2K | 0.00% | −1,051−9.5% | Reduced |
| UBS Group AG | 3,538 | $9.59K | 0.00% | −149,310−97.7% | Reduced |
| Bank of America Corp | 3,239 | $8.78K | 0.00% | −161−4.7% | Reduced |
| SBI Securities Co., Ltd. | 2,500 | $6.78K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 2,000 | $5.42K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 2,000 | $5.00K | 0.00% | +2,000 | New |
| Advisor Group Holdings, Inc. | 90 | $243 | 0.00% | −1,000−91.7% | Reduced |
| JPMorgan Chase & Co | 34 | $92 | 0.00% | 00.0% | Unchanged |
| Larson Financial Group LLC | 22 | $60 | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 1 | $3 | 0.00% | −323−99.7% | Reduced |
| Steward Partners Investment Advisory, LLC | 1 | $3 | 0.00% | +1 | New |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −189,136−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −128,175−100.0% | Sold out |
| Carolina Wealth Advisors, LLC | 0 | $0 | 0.00% | −50−100.0% | Sold out |